Scholten R J, Bijlmer H A, Poolman J T, Kuipers B, Caugant D A, Van Alphen L, Dankert J, Valkenburg H A
Institute for Research in Extramural Medicine, Vrije Universiteit, Amsterdam, The Netherlands.
Clin Infect Dis. 1993 Feb;16(2):237-46. doi: 10.1093/clind/16.2.237.
In order to explain a threefold increase in the incidence of meningococcal disease in the Netherlands during the 1980s, we serotyped and subtyped Neisseria meningitidis isolates recovered between 1958 and 1990 from > 3,000 patients with systemic disease. No single strain could be held responsible for the increase. Apart from the newly introduced strain B:4:P1.4, which became the most prevalent phenotype in 1990 (21% of all isolates), the majority of the cases in 1990 were caused by many different strains that were already present in the Netherlands before 1980. For the period 1980-1990, a shift in the age distribution of patients with meningococcal disease from younger to older age categories was found, particularly with regard to cases due to meningococci of serogroup B; this shift is explained by the changing distribution of serotypes and subtypes within serogroup B. A polyvalent group B, class 1 outer-membrane-protein vaccine of a stable composition could theoretically have prevented approximately 80% of all group B meningococcal infections in the Netherlands during the past 30 years.
为解释20世纪80年代荷兰脑膜炎球菌病发病率增加了两倍的原因,我们对1958年至1990年间从3000多名患有全身性疾病的患者身上分离出的脑膜炎奈瑟菌进行了血清分型和亚型分析。没有单一菌株能对这种增加负责。除了新引入的B:4:P1.4菌株(该菌株在1990年成为最普遍的表型,占所有分离株的21%)外,1990年的大多数病例是由1980年前荷兰就已存在的许多不同菌株引起的。在1980 - 1990年期间,发现脑膜炎球菌病患者的年龄分布从较年轻年龄段向较年长年龄段转变,特别是B群脑膜炎球菌引起的病例;这种转变是由B群血清型和亚型分布的变化所解释的。理论上,一种成分稳定的多价B群1类外膜蛋白疫苗在过去30年里本可预防荷兰约80%的所有B群脑膜炎球菌感染。